Gene Therapy in Treating Patients With Primary Brain Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Inserting the gene for herpes virus into a person's cells may improve the body's
ability to fight cancer or make the cancer more sensitive to chemotherapy using antiviral
drugs such as ganciclovir.
PURPOSE: Phase I trial to study the effectivenesss of gene therapy in treating patients with
primary brain tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania